Aspira Pathlab & Diagnostics Ltd (540788) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 540788 | NSE: | Hospital & Healthcare Services | Small Cap

Aspira Pathlab&Diagn Share Price

68.35 1.60 2.40%
as on 05-Dec'25 15:21

Aspira Pathlab & Diagnostics Ltd (540788) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 540788 | NSE: | Hospital & Healthcare Services | Small Cap

DeciZen - make an informed investing decision on Aspira Pathlab&Diagn

Based on:

M-Cap below 100cr DeciZen not available

Aspira Pathlab & Diagnostics stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
20.19
Market Cap:
68.7 Cr.
52-wk low:
50.5
52-wk high:
106.8

Is Aspira Pathlab & Diagnostics Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Aspira Pathlab&Diagn: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Aspira Pathlab & Diagnostics Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 1.8%-25.4%-38.4%-34.5%-26.3%21.5%41.6%2.4%-18.5%19.6%-
Value Creation
Index
-0.9-2.8-3.7-3.5-2.90.52.0-0.8-2.30.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 00.84.47.68.415.219.514.513.22225
Sales YoY Gr.-NA473.7%75.2%10.2%80.6%28.5%-26%-8.7%66.7%-
Adj EPS 0.1-5.3-10.8-6.3-4.61.34.3-0.1-2.623.3
YoY Gr.--4475%NANANANA223.1%-102.1%NANA-
BVPS (₹) 16.211.40.66.34.18.112.412.49.911.914
Adj Net
Profit
0-2.7-5.6-5.2-4.21.44.5-0.1-2.72.13
Cash Flow from Ops. -0.4-1.3-4.8-3.4-1.95.72-01.11.9-
Debt/CF from Ops. -7.2-5.7-2.4-2.2-4.20.20.4-80.210.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA21.2%4%66.7%
Adj EPS 37%NA-22.2%NA
BVPS-3.4%23.8%-1.5%20.5%
Share Price - 23% 17.6% -5%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
0.8-57-178.6-187.6-94.322.842.3-0.7-23.318.725.6
Op. Profit
Mgn %
0-339.5-88.9-42.5-21.723.132.311-916.219.7
Net Profit
Mgn %
0-359.1-128.1-67.9-50.49.122.8-0.6-20.29.513.9
Debt to
Equity
0.71.233.91.520.20.10.10.10.10.1
Working Cap
Days
01,188353244224899117518712740
Cash Conv.
Cycle
040253229174580592923

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Aspira Pathlab & Diagnostics Ltd.

Standalone Consolidated
TTM EPS (₹) 3.3 2.3
TTM Sales (₹ Cr.) 24.5 22.6
BVPS (₹.) 14 12.3
Reserves (₹ Cr.) 4 2
P/BV 4.76 5.44
PE 20.19 28.64
From the Market
52 Week Low / High (₹) 50.49 / 106.78
All Time Low / High (₹) 14.15 / 124.15
Market Cap (₹ Cr.) 68.7
Equity (₹ Cr.) 10.3
Face Value (₹) 10
Industry PE 90.5

Management X-Ray of Aspira Pathlab&Diagn:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Aspira Pathlab&Diagn - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Aspira Pathlab&Diagn

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales00.764.367.648.4215.2119.5414.4613.2022
Operating Expenses 0.233.348.2310.8810.2411.6913.2312.8614.3918.47
Manufacturing Costs0.030.200.650.840.832.481.781.081.963.41
Material Costs00.141.302.261.992.633.142.502.623.70
Employee Cost 0.081.613.424.474.954.035.025.596.207.33
Other Costs 0.131.382.853.312.482.553.293.703.614.04
Operating Profit -0.23-2.58-3.87-3.25-1.833.516.321.59-1.193.52
Operating Profit Margin (%) --339.0%-88.9%-42.5%-21.7%23.1%32.3%11.0%-9.0%16.0%
Other Income 0.320.310.220.250.290.200.150.320.420.39
Interest 0.050.260.800.961.010.890.370.420.370.35
Depreciation 00.201.121.231.661.441.641.591.541.49
Exceptional Items 0000000000
Profit Before Tax 0.04-2.72-5.58-5.18-4.211.384.46-0.09-2.672.07
Tax 0.01-0000.0300000
Profit After Tax 0.03-2.72-5.58-5.18-4.241.384.46-0.09-2.672.07
PAT Margin (%) --359.0%-128.0%-67.9%-50.4%9.1%22.8%-0.6%-20.2%9.4%
Adjusted EPS (₹)0.1-5.3-10.8-6.3-4.61.34.3-0.1-2.62.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 3.645.920.335.193.808.3112.7912.7510.1412.22
Share Capital 2.255.195.198.199.2910.2910.2910.2910.2910.29
Reserves 1.390.72-4.86-3-5.49-1.982.502.46-0.151.92
Minority Interest0000000000
Debt2.626.7910.596.756.870.770.860.961.081.21
Long Term Debt03.1710.504.784.550.770.860.961.081.21
Short Term Debt2.623.610.091.962.3200000
Trade Payables00.290.230.290.400.660.610.350.730.74
Others Liabilities 0.031.871.382.573.262.033.883.282.763.35
Total Liabilities 6.3014.8612.5314.8014.3411.7818.1417.3414.7117.51

Fixed Assets

Gross Block0.047.999.2311.4512.9113.4116.8716.8817.2018.31
Accumulated Depreciation00.201.332.554.215.667.298.8810.4111.78
Net Fixed Assets 0.047.797.918.908.707.759.578.016.796.53
CWIP 00.2500000000
Investments 0000000000.13
Inventories00.120.370.280.280.370.400.400.450.51
Trade Receivables0.060.090.350.800.601.704.492.342.242.35
Cash Equivalents 5.332.810.220.101.101.191.642.351.382.14
Others Assets 0.873.813.684.733.660.772.024.253.855.85
Total Assets 6.3014.8612.5314.8014.3411.7818.1417.3414.7117.51

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -0.37-1.29-4.81-3.39-1.875.672.03-0.011.051.88
PBT 0.04-2.72-5.58-5.18-4.211.384.46-0.09-2.672.07
Adjustment -0.020.151.711.992.402.362.401.801.771.78
Changes in Working Capital -0.331.29-0.94-0.19-0.031.93-4.83-1.731.96-1.97
Tax Paid -0.0500-0-0.0300000
Cash Flow From Investing Activity -0.02-10.14-0.77-1.970.24-0.09-0.510.160.140.07
Capex -0.04-8.20-1-0.51-0.05-0.30-0.61-0.13-0.26-0.17
Net Investments 0-2.250-1.7100000-0.13
Others 0.020.310.220.250.290.200.090.290.400.37
Cash Flow From Financing Activity 2.648.916.523.351.27-2.17-1.35-0.94-0.95-0.99
Net Proceeds from Shares 0505.102.8630000
Net Proceeds from Borrowing 2.623.177.33-6.29-0.23-3.780.090.100.120.13
Interest Paid 0-0.26-0.80-0.96-1.01-0.89-0.37-0.42-0.37-0.35
Dividend Paid 0000000000
Others 0.010.99-05.50-0.34-0.50-1.07-0.62-0.70-0.78
Net Cash Flow 2.25-2.520.94-2-0.353.410.17-0.790.240.95

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)0.76-57.04-178.61-187.57-94.3222.842.26-0.69-23.3418.54
ROCE (%)1.78-25.35-38.38-34.5-26.321.5241.632.4-18.4919.64
Asset Turnover Ratio00.070.320.560.581.161.310.820.821.37
PAT to CFO Conversion(x)-12.33N/AN/AN/AN/A4.110.46N/AN/A0.91
Working Capital Days
Receivable Days0351928302858866338
Inventory Days0572016128710128
Payable Days07367242637474707572

Aspira Pathlab & Diagnostics Ltd Stock News

Aspira Pathlab & Diagnostics Ltd FAQs

The current trading price of Aspira Pathlab&Diagn on 05-Dec-2025 15:21 is ₹68.35.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Aspira Pathlab&Diagn stood at ₹68.71.
The latest P/E ratio of Aspira Pathlab&Diagn as of 04-Dec-2025 is 20.19.
The latest P/B ratio of Aspira Pathlab&Diagn as of 04-Dec-2025 is 4.76.
The 52-week high of Aspira Pathlab&Diagn is ₹106.8 and the 52-week low is ₹50.49.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Aspira Pathlab&Diagn is ₹24.52 ( Cr.) .

About Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab & Diagnostics Limited is a public limited company incorporated and domiciled in India. The company is engaged in the business of running, owning, managing and administering Diagnostics Centers. The principal activities of the Company consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai.

It has its registered office at Shraddhanand Road Opp. Ghatkopar Railway Station, Ghatkopar (West) Mumbai, Maharashtra, India.

The Board of Directors of the Company, which has been identified as being the chief operating decision maker (CODM), evaluates the Company’s performance, allocate resources based on the analysis of the various performance indicator of the Company as a single unit. 

Business area of the company

The Company is solely engaged in the business of running laboratories for carrying out Pathological investigations in various branches of Bio-chemistry, Hematology, Histopathology, Microbiology, Immuno-chemistry, Immunology, Virology, Cytology, other pathological and radiological investigations.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×